Cohance Lifesciences Limited
COHANCE
Rang in aandelen
#6486
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aandeelprijs
$4.80
Marktkapitalisatie
$1.84B
Verandering (1 dag)
-5.65%
Verandering (1 jaar)
-59.50%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Categorie
Healthcare
Koersgeschiedenis voor Cohance Lifesciences Limited (COHANCE)
Hoogste slotkoers: $12.03 op 2025-06-01
Laagste slotkoers: $1.65 op 2020-03-01
Laagste slotkoers: $1.65 op 2020-03-01
Koersgeschiedenis van Cohance Lifesciences Limited van 2020 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2025 | -17.24% |
| 2024 | 75.72% |
| 2023 | 43.40% |
| 2022 | -12.41% |
| 2021 | 15.53% |
| 2020 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
